CDKN2A and pancreatic neoplasm: Ectopic expression studies in p16-null pancreatic cancer cells demonstrated that p16-L16R exhibited lower protein levels than wild-type (WT) p16 (p16-WT) and that p16-L16R almost completely lacked cell cycle inhibitory function.